Actionable diagnosis of neuroleptospirosis by next-generation sequencing.
Actionable diagnosis of neuroleptospirosis by next-generation sequencing.
复制标题
DOI:
10.1056/nejmoa1401268
复制
发表时间:
2014-06-19
期刊:
影响因子:
--
通讯作者:
Chiu CY
中科院分区:
文献类型:
--
作者:
Wilson MR;Naccache SN;Samayoa E;Biagtan M;Bashir H;Yu G;Salamat SM;Somasekar S;Federman S;Miller S;Sokolic R;Garabedian E;Candotti F;Buckley RH;Reed KD;Meyer TL;Seroogy CM;Galloway R;Henderson SL;Gern JE;DeRisi JL;Chiu CY
A 14-year-old boy with severe combined immunodeficiency presented three times to a medical facility over a period of 4 months with fever and headache that progressed to hydrocephalus and status epilepticus necessitating a medically induced coma. Diagnostic workup including brain biopsy was unrevealing. Unbiased next-generation sequencing of the cerebrospinal fluid identified 475 of 3,063,784 sequence reads (0.016%) corresponding to leptospira infection. Clinical assays for leptospirosis were negative. Targeted antimicrobial agents were administered, and the patient was discharged home 32 days later with a status close to his premorbid condition. Polymerase-chain-reaction (PCR) and serologic testing at the Centers for Disease Control and Prevention (CDC) subsequently confirmed evidence of Leptospira santarosai infection.